• 信息
  • 详情
  • 联系
  • 推荐
分享好友 产品首页 产品分类 切换频道
1/5
Recombinant Cynomolgus Monkey GITR/TNFRSF18 Fc Chimera, CF  100 UG图1

Recombinant Cynomolgus Monkey GITR/TNFRSF18 Fc Chimera, CF 100 UG

2024-11-24 20:13IP属地 广东省东莞市 电信00留言

9428-GR

 

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.


Reconstitution Reconstitute at 500 μg/mL in PBS.



Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.


Stability & Storage:       Use a manual defrost freezer and avoid repeated freeze-thaw cycles.      

  • 12 months from date of receipt, -20 to -70 °C as supplied.

  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.

  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.


Data Images

Bioactivity      


       

When Recombinant Cynomolgus Monkey GITR/TNFRSF18 Fc Chimera (Catalog # 9428‑GR) is immobilized at 0.5 µg/mL, biotinylated recombinant human GITRLigand/TNFSF18 binds with an ED50 of 8-40 ng/mL.

Background: GITR/TNFRSF18

GITR (glucocorticoid-induced tumor necrosis factor receptor), also known as AITR and TNFRSF18, is a 40 kDa transmembrane glycoprotein that functions in immune regulation (1, 2). Mature human GITR consists of a 137 amino acid (aa) extracellular domain (ECD) with three tandem TNF R cysteine-rich repeats, a 21 aa transmembrane segment, and a 58 aa cytoplasmic domain (3, 4). Within the ECD region, cyno GITR shares 89.8% and 53.2% aa sequence identity with human and mouse GITR, respectively. Alternative splicing generates an isoform with a short deletion in the cytoplasmic domain and a potentially secreted isoform that is substituted within the third TNF R repeat and lacks the transmembrane and cytoplasmic regions. GITR is expressed on CD4  +CD25  + regulatory T cells (Treg) as well as on subsets of thymocytes, lymph node cells, and splenocytes (4-6), and it is up-regulated on antigen-activated conventional CD4  + and CD8  + T cells (3, 4, 6, 7). GITR binding by GITR Ligand/TNFSF18 co-stimulates the proliferation and activation of CD4  + or CD8  + conventional T cells (3, 7-9). It also induces the proliferation of Treg (8, 10) but inhibits the ability of Treg to suppress immune responses (5, 8, 11-13). This can result in the development of autoimmunity, increased tumor cell killing by effector T cells (5, 11), and increased inflammation in arthritis, allergic asthma, and inflammatory bowel disease (10, 14). GITR is also expressed on sympathetic neurons where it enhances NGF-induced neurite outgrowth and branching (15).

举报
收藏 0
评论 0
联系方式